{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T12:31:49Z","timestamp":1786710709252,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstertreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["F&S Reports"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xfre.2026.05.001","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:08Z","timestamp":1778284808000},"page":"301-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Cardinal protocol: investigating a simplified, cost-conscious option for oocyte cryopreservation in a prospective noninferiority cohort study"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7593-3719","authenticated-orcid":false,"given":"Esther H.","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Raj-Derouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Harbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metabel","family":"Markwei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arian","family":"Khorshid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brindha","family":"Bavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lusine","family":"Aghajanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth B.","family":"Lathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xfre.2026.05.001_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.fertnstert.2021.02.019","article-title":"Disparities in access to effective treatment for infertility in the United States: an Ethics Committee opinion","volume":"116","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2026.05.001_bib3","article-title":"Access to Care Summit [Internet]","year":"2015","journal-title":"ASRM"},{"key":"10.1016\/j.xfre.2026.05.001_bib4","first-page":"66","article-title":"Current options to lower the cost of in vitro fertilization: a comprehensive review","volume":"4","author":"Gardner","year":"2023","journal-title":"FS Rev"},{"key":"10.1016\/j.xfre.2026.05.001_bib5","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.fertnstert.2017.06.035","article-title":"Outcomes from a university-based low-cost in vitro fertilization program providing access to care for a low-resource socioculturally diverse urban community","volume":"108","author":"Herndon","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2026.05.001_bib6","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.3390\/jcm12103542","article-title":"Oocyte cryopreservation for medical and planned indications: a practical guide and overview","volume":"12","author":"Han","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.xfre.2026.05.001_bib7","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.fertnstert.2022.07.022","article-title":"A SART data cost-effectiveness analysis of planned oocyte cryopreservation versus in vitro fertilization with preimplantation genetic testing for aneuploidy considering ideal family size","volume":"118","author":"Bakkensen","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2026.05.001_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2023.103639","article-title":"Progestin-primed ovarian stimulation: for whom, when and how?","volume":"48","author":"Ata","year":"2024","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.xfre.2026.05.001_bib9","article-title":"The Stanford egg freezing Study: investigating a low-cost, low-intensity oocyte cryopreservation protocol [Clinical trial registration]","author":"Lathi","year":"2025","journal-title":"clinicaltrials.gov"},{"key":"10.1016\/j.xfre.2026.05.001_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12958-021-00884-0","article-title":"Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation","volume":"20","author":"Walker","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.xfre.2026.05.001_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hox018","article-title":"How much variation in oocyte yield after controlled ovarian stimulation can be explained? A multilevel modelling study","volume":"2017","author":"Rustamov","year":"2017","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.xfre.2026.05.001_bib14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/humrep\/dex008","article-title":"Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients","volume":"32","author":"Goldman","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2026.05.001_bib15","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.fertnstert.2021.01.011","article-title":"Planned oocyte cryopreservation-10-15-year follow-up: return rates and cycle outcomes","volume":"115","author":"Blakemore","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2026.05.001_bib16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.fertnstert.2023.08.001","article-title":"Race, ovarian responsiveness, and live birth after in vitro fertilization","volume":"120","author":"Lee","year":"2023","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2026.05.001_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","article-title":"Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses","volume":"27","author":"Ata","year":"2021","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfre.2026.05.001_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2026.05.001_bib19","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/1471-0528.14622","article-title":"The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial","volume":"124","author":"Dong","year":"2017","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.xfre.2026.05.001_bib20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.fertnstert.2021.02.036","article-title":"Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial","volume":"116","author":"Giles","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2026.05.001_bib21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.fertnstert.2019.06.009","article-title":"Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology","volume":"112","author":"Yildiz","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2026.05.001_bib22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/14647273.2020.1794060","article-title":"Effectiveness of the flexible progestin primed ovarian stimulation protocol compared to the flexible GnRH antagonist protocol in women with decreased ovarian reserve","volume":"25","author":"Turkgeldi","year":"2022","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.xfre.2026.05.001_bib23","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s10815-020-01894-4","article-title":"Medroxyprogesterone acetate used in ovarian stimulation is associated with reduced mature oocyte retrieval and blastocyst development: a matched cohort study of 825 freeze-all IVF cycles","volume":"37","author":"Ozgur","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.xfre.2026.05.001_bib24","first-page":"1098","article-title":"Ovarian response and embryo ploidy following oral micronized progesterone-primed ovarian stimulation versus GnRH antagonist protocol","volume":"39","author":"Vidal","year":"2024","journal-title":"A prospective study with repeated ovarian stimulation cycles. Hum Reprod"},{"key":"10.1016\/j.xfre.2026.05.001_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1472-6874-12-29","article-title":"The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial","volume":"12","author":"van Tilborg","year":"2012","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.xfre.2026.05.001_bib26","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1093\/humrep\/dex321","article-title":"Individualized FSH dosing based on ovarian reserve testing in women starting IVF\/ICSI: a multicentre trial and cost-effectiveness analysis","volume":"32","author":"van Tilborg","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2026.05.001_bib27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/humupd\/dmq041","article-title":"Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis","volume":"17","author":"Sterrenburg","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfre.2026.05.001_bib28","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1093\/humrep\/deaa107","article-title":"GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study","volume":"35","author":"Haas","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2026.05.001_bib29","first-page":"63","article-title":"Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization","volume":"59","author":"Kim","year":"2014","journal-title":"J Reprod Med"},{"key":"10.1016\/j.xfre.2026.05.001_bib30","article-title":"Dual trigger using recombinant HCG and gonadotropin-releasing hormone agonist improve oocyte maturity and embryo grading for normal responders in GnRH antagonist cycles: randomized controlled trial","volume":"49","author":"Ali","year":"2020","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.xfre.2026.05.001_bib31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12958-021-00766-5","article-title":"GnRH agonist and hCG (dual trigger) versus hCG trigger for follicular maturation: a systematic review and meta-analysis of randomized trials","volume":"19","author":"Hu","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.xfre.2026.05.001_bib32","doi-asserted-by":"crossref","DOI":"10.1530\/RAF-24-0095","article-title":"A cost analysis of hCG trigger alone versus dual trigger for achieving live birth following in vitro fertilization","volume":"6","author":"Chung","year":"2025","journal-title":"Reprod Fertil"},{"key":"10.1016\/j.xfre.2026.05.001_bib33","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.fertnstert.2021.12.015","article-title":"Racial and ethnic disparities among donor oocyte banks in the United States","volume":"117","author":"Tsai","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2026.05.001_bib34","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.fertnstert.2008.10.061","article-title":"Racial and ethnic disparities in assisted reproductive technology outcomes in the United States","volume":"93","author":"Fujimoto","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2026.05.001_bib35","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.fertnstert.2007.08.024","article-title":"Disparity in assisted reproductive technologies outcomes in black women compared with white women","volume":"90","author":"Seifer","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2026.05.001_bib36","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.fertnstert.2010.02.021","article-title":"Will decreasing assisted reproduction technology costs improve utilization and outcomes among minority women?","volume":"94","author":"McCarthy-Keith","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2026.05.001_bib38","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.fertnstert.2024.06.022","article-title":"Feasibility and efficacy of a subcutaneous catheter for controlled ovarian stimulation","volume":"122","author":"Mandelbaum","year":"2024","journal-title":"Fertil Steril"}],"container-title":["F&S Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666334126000711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666334126000711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:35:23Z","timestamp":1786707323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666334126000711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666334126000711"],"URL":"https:\/\/doi.org\/10.1016\/j.xfre.2026.05.001","relation":{},"ISSN":["2666-3341"],"issn-type":[{"value":"2666-3341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Cardinal protocol: investigating a simplified, cost-conscious option for oocyte cryopreservation in a prospective noninferiority cohort study","name":"articletitle","label":"Article Title"},{"value":"F&S Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xfre.2026.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}